Anuncia Medical

Anuncia Medical is a neurotherapeutic medical device company based in Scottsdale, Arizona, specializing in cerebrospinal fluid (CSF) management and neurocritical care solutions. The company develops noninvasive, clinically validated breakthrough devices designed to monitor, treat, and prevent shunt occlusions in patients with hydrocephalus. The ReFlow™ System Mini (ReFlow™ Mini Flusher) is their primary offering—an implantable device that allows patients to perform noninvasive CSF flushes by pressing the flusher located under the scalp, potentially restoring or maintaining shunt patency and reducing the need for repeat revision brain surgeries. The device received FDA Breakthrough Device Designation, indicating significant clinical potential. Anuncia addresses the substantial unmet need in hydrocephalus management, particularly affecting pediatric and geriatric populations. The company's team comprises medical device veterans collaborating with leading institutions and clinicians. Their technology targets both in-clinic and at-home management scenarios, reducing patient morbidity and healthcare costs associated with shunt revision procedures. The ReFlow™ Mini Flusher can be used with the ReFlow™ Ventricular Catheter, which features a relief membrane backup option providing alternate CSF flow pathways. Regulatory credentials include FDA Breakthrough Device Designation. The company actively engages with patient communities and professional associations to support hydrocephalus awareness and clinical education.